Atlas Trials

Pharmacokinetic Boosting of Osimertinib

Clinical trial NCT03858491 · COMPLETED

Trial details

NCT number
NCT03858491
Sponsor
Academisch Ziekenhuis Maastricht
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2020-11-01
Primary completion
2021-10-31
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.